The long-awaited 2017-2027 Quebec Life Sciences Strategy is positioning the province to be in the top five North American life sciences clusters within a decade. The strategy aims to leverage its scientific expertise, particularly in precision medicine and big data, by attracting $4 billion in private investment to boost industry employment and increase the number of Quebec-based firms and their contribution to provincial GDP.
Organizations: | BlueRock Therapeutics, Fonds de solidarite FTQ, MEDTEQ, Montreal International, Quebec |Mnistry of Economy, and Science and Innovation |
People: | Didier Leconte, Dominique Anglade, and Hubert Bolduc |
Topics: | Quebec life sciences strategy |